FindTrial
Sign In

Sentinel node biopsy in the detection of cervical occult lymph node metastases in patients with parotid gland carcinoma.

Sentinel node biopsy in the detection of cervical occult lymph node metastases in patients with parotid gland carcinoma. - SNparotis-study

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON32680
Enrollment
20
Registered
2008-10-21
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

parotid carcinoma

Interventions

None listed

Sponsors

Vrije Universiteit Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients with carcinoma of the parotid gland No lymph node metastases on CT, MRI or USgFNAC Scheduled for parotidectomy and elective (selective or modified radical) neck dissection

Exclusion criteria

Exclusion criteria: Clinical lymph node metastases

Design outcomes

Primary

MeasureTime frame
Primary endpoint is the feasibility and validation of the sentinel node biopsy procedure in patients with carcinoma of the parotid gland with N0 neck scheduled for parotidectomy with elective neck dissection.—

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)